Postpartum haemorrhage in a woman with essential thrombocythemia carrying calreticulin mutation: a case report

Blood Coagul Fibrinolysis. 2016 Sep;27(6):727-8. doi: 10.1097/MBC.0000000000000473.

Abstract

Coagulation disorder associated with essential thrombocythemia may exacerbate the prothrombotic state physiologically occurring during pregnancy. We report a case of a severe postpartum haemorrhage in a 35-year-old woman previously diagnosed with essential thrombocythemia and carrying the somatic calreticulin mutation. She was referred to our Thrombosis and Haemostasis Unit for pregnancy management. A treatment with low-dose aspirin was prescribed until the labour started, as the platelets count raised above 1000 × 10/l. At the time of bleeding, no residual placenta was detected at the revision of the uterine cavity.Although the postpartum is a high-risk period for thrombotic events, we have to carefully evaluate in women with essential thrombocythemia the likelihood of developing a hemorrhagic complication.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aspirin / therapeutic use
  • Calreticulin / genetics*
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Mutation*
  • Postpartum Hemorrhage / diagnosis*
  • Postpartum Hemorrhage / drug therapy
  • Postpartum Hemorrhage / genetics
  • Postpartum Hemorrhage / pathology
  • Pregnancy
  • Thrombocythemia, Essential / diagnosis*
  • Thrombocythemia, Essential / drug therapy
  • Thrombocythemia, Essential / genetics
  • Thrombocythemia, Essential / pathology

Substances

  • CALR protein, human
  • Calreticulin
  • Fibrinolytic Agents
  • Aspirin